Journal article · 2026 · Open access
ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY
European Journal Pharmaceutical and Medical Research · Published 10 May 2026 · DOI 10.5281/zenodo.20135394
In brief
“ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY” is a 2026 journal article by Rajiv Kukkar2 Ramanamma Lalam*1, published in European Journal Pharmaceutical and Medical Research. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at European Journal Pharmaceutical and Medical Research.
- Citations
- 0
- Authors
- 1
Abstract
The present work focuses on the concept of bioavailability and the challenges associated with poorly water-soluble drugs, particularly those belonging to Biopharmaceutical Classification System (BCS) Class II and IV. Bioavailability plays a crucial role in determining the therapeutic effectiveness of a drug, as it reflects the rate and extent of drug absorption into systemic circulation. A major limitation in modern drug development is poor aqueous solubility, which leads to dissolution-limited absorption and reduced bioavailability. Various approaches have been explored to overcome this issue, including chemical modification, physical modification, solvent-based techniques, and carrier-mediated drug delivery systems. Among these, nanosuspension technology has emerged as a promising and efficient strategy. Nanosuspensions, consisting of drug particles in the nanometer range stabilized by surfactants or polymers, significantly enhance dissolution rate, saturation solubility, and bioavailability. Techniques such as high-pressure homogenization, media milling, antisolvent precipitation, and combinational methods have been widely employed for nanosuspension preparation. The study highlights the advantages, limitations, and industrial applicability of nanosuspension systems, demonstrating their potential as a versatile approach for improving the therapeutic performance of poorly soluble drugs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Lalam*1, R. K. R. (2026). ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY. European Journal Pharmaceutical and Medical Research. https://doi.org/10.5281/zenodo.20135394
MLA 9
Lalam*1, Rajiv Kukkar2 Ramanamma. “ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY.” European Journal Pharmaceutical and Medical Research, 2026. https://doi.org/10.5281/zenodo.20135394.
Chicago
Lalam*1, Rajiv Kukkar2 Ramanamma. 2026. “ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY.” European Journal Pharmaceutical and Medical Research. https://doi.org/10.5281/zenodo.20135394.
Harvard
Lalam*1, R. K. R. (2026) ‘ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY’, European Journal Pharmaceutical and Medical Research. doi:10.5281/zenodo.20135394.
IEEE
R. K. R. Lalam*1, “ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY,” European Journal Pharmaceutical and Medical Research, 2026, doi: 10.5281/zenodo.20135394.
BibTeX
@article{lalam12026enhancement,
title = {{ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY}},
author = {Lalam*1, Rajiv Kukkar2 Ramanamma},
journal = {European Journal Pharmaceutical and Medical Research},
year = {2026},
doi = {10.5281/zenodo.20135394},
url = {https://doi.org/10.5281/zenodo.20135394}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- nanoparticle suspensions
- oral bioavailability
- poorly water-soluble drugs
- BCS Class II and IV drugs
- dissolution enhancement
- saturation solubility
- high-pressure homogenization
- media milling
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Lalam*1, R. K. R. (2026). ENHANCEMENT OF ORAL BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUGS USING NANOSUSPENSION TECHNOLOGY: A COMPREHENSIVE STUDY. European Journal Pharmaceutical and Medical Research. https://doi.org/10.5281/zenodo.20135394
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at European Journal Pharmaceutical and Medical Research.
Who wrote this paper?
Rajiv Kukkar2 Ramanamma Lalam*1.
What is the DOI of this paper?
10.5281/zenodo.20135394. The permanent link is https://doi.org/10.5281/zenodo.20135394.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.